Peimisine

SKU: orb1301350

Description

Peimisine (Ebeiensine) is a research compound with demonstrated bioactivity in models of asthma, acute lung injury, hepatic fibrosis, and hypertension. Its mechanisms include tracheal smooth muscle relaxation via M-receptor modulation and nitric oxide release, as well as protective effects against LPS-induced lung injury and angiotensin-converting enzyme inhibition.

Research Area

Cell Biology, Metabolism Research, Neuroscience

Key Properties

• CAS Number: 19773-24-1
• MW: 427.62
• Purity: 98.99%
• Formula: C₂₇H₄₁NO₃
• SMILES: C[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@]11CC[C@H]2[C@@H]3CC(=O)[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC2=C1C
• Target: Angiotensin-converting Enzyme (ACE),AChR,Apoptosis,RAAS
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.34 mM);DMSO:9 mg/mL (21.05 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

mAChR, Muscarinic acetylcholine receptor, muscarinic M receptor, induce apoptosis, LLC, inhibit, HepG2, Inhibitor, ACE, A549, A2780, anti-inflammatory activity, antihypertensive activity, anti-tumor activity, Angiotensin-converting Enzyme (ACE), angiotensin converting enzyme, angiotensin I converting enzyme (ACE1), asthma, cough, Ebeiensine, Peimisine

Compound Identifiers

PubChem CID

161294